Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 15, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 15, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 155,425 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 11,887 · Balance 155,425 F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 23, 2026 00:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 11,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-029339 · form4.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,425 F1 · shares: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 22:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-026454 · form4.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,538 F1 · shares: The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 21:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 20,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-033632 · form4.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,863 F1 · shares: The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 01:11 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-035724 · form4.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,322 F1 · shares: The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 22:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014357 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,281 F1 · shares: The acquisition of 7,060 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:16 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon- Qualified Stock Option (right to buy) · Derivative | 6,022 | $0.00 Strike: $15.95 | $0.00 |
DisclosureSEC source: 0001567619-22-014116 · doc1.xml · derivative · entry 3 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,022 shares Expires 2022-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options for one-third of the shares were each exercisable beginning 7/22/2016, 7/22/2017 and 7/22/2018, respectively. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:16 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 4,505 | $21.32 | $96,046.60 |
DisclosureSEC source: 0001567619-22-014116 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,221 F1 · shares: The exempt disposition of 4,505 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:16 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 6,022 | $15.95 | $96,050.90 |
DisclosureSEC source: 0001567619-22-014116 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 20:07 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | SaleCommon Stock | 1,299 | $23.26 | $30,214.74 |
DisclosureSEC source: 0001567619-22-008484 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,704 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.20 to $23.36, inclusive. The reporting person has provided to the Company, and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:07 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | SaleCommon Stock | 6,201 | $23.00 | $142,623.00 |
DisclosureSEC source: 0001567619-22-008484 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,003 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.01, inclusive. The reporting person has provided to AngioDynamics, Inc. (the "Company"), and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 22:27 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,726 | $0.00 Strike: $14.64 | $0.00 |
DisclosureSEC source: 0001567619-21-014231 · doc1.xml · derivative · entry 3 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,726 shares Expires 2021-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-third of the shares were each exercisable beginning 8/12/2015, 8/12/2016 and 8/12/2017, respectively. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 22:27 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 3,171 | $26.43 | $83,809.53 |
DisclosureSEC source: 0001567619-21-014231 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,204 Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 22:27 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 5,726 | $14.64 | $83,828.64 |
DisclosureSEC source: 0001567619-21-014231 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 23:14 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 5,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-013937 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,649 F1 · shares: The acquisition of 5,738 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 5,738 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/21/2022. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 15:15 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | SaleCommon Stock | 6,500 | $18.53 | $120,445.00 |
DisclosureSEC source: 0001567619-21-001303 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,911 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.02 to $18.89, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 23:11 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 15,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-013367 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,411 F1 · shares: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021. Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 21:41 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,650 | $0.00 Strike: $10.68 | $0.00 |
DisclosureSEC source: 0001567619-19-016192 · doc1.xml · derivative · entry 3 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,650 shares Expires 2019-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for 25% of the shares each became exercisable on 08/07/2013, 08/07/2014, 08/07/2015 and 08/07/2016, respectively. Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 21:41 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 3,581 | $19.83 | $71,011.23 |
DisclosureSEC source: 0001567619-19-016192 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,088 Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 21:41 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 6,650 | $10.68 | $71,022.00 |
DisclosureSEC source: 0001567619-19-016192 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2019 Filed Jul 20, 2019 01:22 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015035 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,019 F1 · shares: The acquisition of 7,057 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,057 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/17/2020. Read SEC document |
| July 18, 2018 Filed Jul 21, 2018 01:25 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 6,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-033083 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,962 F1 · shares: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 20:20 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001140361-18-029780 · doc1.xml · derivative · entry 3 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-third of the shares became exercisable on 8/3/2012, 8/3/2013 and 8/3/2014, respectively. Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 20:20 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 8,319 | $22.77 | $189,423.63 |
DisclosureSEC source: 0001140361-18-029780 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,655 Read SEC document |
| June 22, 2018 Filed Jun 25, 2018 20:20 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $13.53 | $189,420.00 |
DisclosureSEC source: 0001140361-18-029780 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 19:37 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-029110 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,974 F1 · shares: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018. Read SEC document |
| July 25, 2017 Filed Aug 8, 2017 21:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $15.75 | $0.00 |
DisclosureSEC source: 0001140361-17-030643 · doc1.xml · derivative · entry 3 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2017-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 08/03/2011, 08/03/2012 and 08/03/2013, respectively. Read SEC document |
| July 25, 2017 Filed Aug 8, 2017 21:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 12,879 | $17.12 | $220,488.48 |
DisclosureSEC source: 0001140361-17-030643 · doc1.xml · nonDerivative · entry 2 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,095 Read SEC document |
| July 25, 2017 Filed Aug 8, 2017 21:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $15.75 | $220,500.00 |
DisclosureSEC source: 0001140361-17-030643 · doc1.xml · nonDerivative · entry 1 JOHNSON WESLEY · CIK 0001258791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.